Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats

Neuropharmacology

Volumn 62, Issue 3, 2012, Pages 1182-1190

  Rodefer, Joshua S ^a   Saland, Samantha K ^a   Eckrich, Samuel J ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Attention; Cognition; Executive function; Frontal cortex; Learning; Set shifting

Indexed keywords

BAY 60 7550; ESTERASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PAPAVERINE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; INTRACELLULAR SIGNALING; MALE; MENTAL TASK; NEUROMODULATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; RAT; SCHIZOPHRENIA; TASK PERFORMANCE;

ANIMALS; COGNITION; MALE; NEUROPSYCHOLOGICAL TESTS; PHENCYCLIDINE; PHOSPHODIESTERASE INHIBITORS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, LONG-EVANS;

EID: 84856078086     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.08.008     Document Type: Article

References (97)

1. M. Barad, R. Bourtchouladze, D.G. Winder, H. Golan, and E. Kandel Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory Proc. Natl. Acad. Sci. U S A 95 25 1998 15020 15025 (Pubitemid 29003749)
2. M.D. Barense, M.T. Fox, and M.G. Baxter Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats Learn. Mem. 9 4 2002 191 201 (Pubitemid 36240691)
3. M.G. Baxter P.R. Hof, C.V. Mobbs, Cognitive Aging in Nonhuman Primates 2001 Academic Press San Diego 407 419
4. A. Becker, and G. Grecksch Phosphodiesterase inhibitors - are they potential neuroleptic drugs? Behav. Brain Res. 186 2008 155 160 (Pubitemid 350122747)
5. J.M. Birrell, and V.J. Brown Medial frontal cortex mediates perceptual attentional set shifting in the rat J. Neurosci. 20 11 2000 4320 4324 (Pubitemid 30365702)
6. E. Bischoff Potency, selectivity, and consequences of nonselectivity of PDE inhibition Int. J. Impot Res. 16 Suppl. 1 2004 Jun S11 S14
7. F.G. Boess, M. Hendrix, F.J. van der Staay, C. Erb, R. Schreiber, W. van Staveren, J. de Vente, J. Prickaerts, A. Blokland, and G. Koenig Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance Neuropharmacology 47 7 2004 Dec 1081 1092 (Pubitemid 39535847)
8. J.L. Bradshaw, and D.M. Sheppard The neurodevelopmental frontostriatal disorders: evolutionary adaptiveness and anomalous lateralization Brain Lang. 73 2 2000 297 320 (Pubitemid 30408053)
9. N.N. Braun, T.J. Reutiman, S. Lee, T.D. Folsom, and S.H. Fatemi Expression of phosphodiesterase 4 is altered in the brains of subjects with autism Neuroreport 18 17 2007 Nov 19 1841 1844 (Pubitemid 350303763)
10. S.L. Brown, C.A. Haas, M. Koehler, D.R. Bodner, and A.D. Seftel Hepatotoxicity related to intracavernous pharmacotherapy with papaverine Urology 52 5 1998 844 847 (Pubitemid 28489715)
11. K.C. Chen, M.G. Baxter, and J.S. Rodefer Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set-shifting Eur. J. Neurosci. 20 4 2004 1081 1088 (Pubitemid 39141315)
12. D.L. Chutae, J.W. Villiger, and N.F. Kirton Testing cyclic AMP mediation of memory: reversal of alpha-methyl-p-tyrosine-induced amnesia Psychopharmacology (Berl.) 74 2 1981 129 131 (Pubitemid 11126540)
13. J.O. Cole, R.J. Branconnier, and G.F. Martin Electroencephalographic and behavioral changes associated with papaverine administration in healthy geriatric subjects J. Am. Geriatr. Soc. 23 7 1975 295 300
14. M. Conti, and S.L.C. Jin The molecular biology of phosphodiesterases Prog. Nucleic Acid Res. Molec Biol. 63 1999 1 38
15. J. de Vente, M. Markerink-van Ittersum, and J.S. Vles The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord J. Chem. Neuroanat. 31 4 2006 Jun 275 303 (Epub 2006 Apr 18) (Pubitemid 43668706)
16. B.D. Devan, J.L. Bowker, K.B. Duffy, I.S. Bharati, M. Jimenez, D. Sierra-Mercado Jr.; C.M. Nelson, E.L. Spangler, and D.K. Ingram Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition Psychopharmacology (Berl.) 183 4 2006 Jan 439 445 (Pubitemid 41721145)
17. R. Dias, T.W. Robbins, and A.C. Roberts Dissociation in prefrontal cortex of affective and attentional shifts Nature 380 6569 1996 69 72 (Pubitemid 26076238)
18. R. Dias, T.W. Robbins, and A.C. Roberts Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from "on-line" processing J. Neurosci. 17 23 1997 9285 9297 (Pubitemid 27498455)
19. K. Domek-Łopacińska, and J.B. Strosznajder The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging Brain Res. 1216 2008 Jun 24 68 77
20. T. Egawa, K. Mishima, Y. Matsumoto, K. Iwasaki, K. Iwasaki, and M. Fujiwara Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats Jpn. J. Pharmacol. 75 3 1997 275 281 (Pubitemid 28000172)
21. J.J. Evans, S.E. Chua, P.J. McKenna, and B.A. Wilson Assessment of the dysexecutive syndrome in schizophrenia Psychol. Med. 27 3 1997 May 635 646 (Pubitemid 27216189)
22. S.B. Floresco, O. Magyar, S. Ghods-Sharifi, C. Vexelman, and M.T. Tse Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting Neuropsychopharmacology 31 2 2006 Feb 297 309 (Pubitemid 43113395)
23. M.T. Fox, M.D. Barense, and M.G. Baxter Perceptual attentional set-shifting is impaired in rats with neurotoxic lesions of posterior parietal cortex J. Neurosci. 23 2 2003 676 681 (Pubitemid 36139566)
24. U. Frey, Y.Y. Huang, and E.R. Kandel Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons Science 260 5114 1993 Jun 11 1661 1664 (Pubitemid 23247151)
25. D.C. Goff, C. Cather, O. Freudenreich, D.C. Henderson, A.E. Evins, M.A. Culhane, and J.P. Walsh A placebo-controlled study of sildenafil effects on cognition in schizophrenia Psychopharmacology (Berl.) 202 1-3 2009 Jan 411 417 (Epub 2008 Aug 21)
26. K. Goto, H. Mochizuki, T. Hattori, N. Nakamura, and Y. Mizuno Neurotoxic effects of papaverine, tetrahydropapaverine and dimethoxyphenylethylamine on dopaminergic neurons in ventral mesencephalic-striatal co-culture Brain Res. 754 1-2 1997 260 268 (Pubitemid 27170275)
27. S.M. Grauer, V.L. Pulito, R.L. Navarra, M.P. Kelly, C. Kelley, R. Graf, B. Langen, S. Logue, J. Brennan, L. Jiang, E. Charych, U. Egerland, F. Liu, K.L. Marquis, M. Malamas, T. Hage, T.A. Comery, and N.J. Brandon Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia J. Pharmacol. Exp. Ther. 331 2 2009 Nov 574 590
28. A.M. Graybiel The basal ganglia Curr. Biol. 10 14 2000 R509 R511
29. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153 1996 321 330 (Pubitemid 26074706)
30. M.E. Green Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions Am. J. Psychiatry 164 2007 992 994
31. T.B. Halene, and S.J. Siegel Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2- imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle J. Pharmacol. Exp. Ther. 326 1 2008 Jul 230 239 (Epub 2008 Apr 17) (Pubitemid 351872113)
32. A.L.O. Hebb, H.A. Robertson, and E.M. Denovan-Wright Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice Eur. Neuropsychopharmacol. 18 2008 339 363 (Pubitemid 351381352)
33. T. Imanishi, A. Sawa, Y. Ichimaru, M. Miyashiro, S. Kato, T. Yamamoto, and S. Ueki Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents Eur. J. Pharmacol. 321 3 1997 Mar 5 273 278 (Pubitemid 27105928)
34. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 3 1999 Mar 201 225 (Pubitemid 29067401)
35. J.D. Jentsch, and J.R. Taylor Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats Neuropsychopharmacology 24 1 2001 Jan 66 74
36. J.D. Jentsch, D.E. Redmond, J.D. Elsworth, J.R. Taylor, K.D. Youngren, and R.H. Roth Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine Science 277 1997 953 955 (Pubitemid 27366680)
37. J.D. Jentsch, J.R. Taylor, and R.H. Roth Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion Neuropsychopharmacology 19 2 1998 Aug 105 113 (Pubitemid 28288436)
38. H. Ke Implications of PDE4 structure on inhibitor selectivity across PDE families Int. J. Impot Res. 16 Suppl. 1 2004 Jun S24 S27
39. A.C. Lahti, M.A. Weiler, B.A. Tamara Michaelidis, A. Parwani, and C.A. Tamminga Effects of ketamine in normal and schizophrenic volunteers Neuropsychopharmacology 25 4 2001 Oct 455 467 (Pubitemid 32830950)
40. V. Lakics, E.H. Karran, and F.G. Boess Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues Neuropharmacology 59 6 2010 Nov 367 374
41. G. Levallet, M. Hotte, M. Boulouard, and F. Dauphin Increased particulate phosphodiesterase 4 in the prefrontal cortex supports 5-HT4 receptor-induced improvement of object recognition memory in the rat Psychopharmacology (Berl.) 202 2009 125 139
42. K. Loughney, T.R. Hill, V.A. Florio, L. Uher, G.J. Rosman, S.L. Wolda, B.A. Jones, M.L. Howard, L.M. McAllister-Lucas, W.K. Sonnenburg, S.H. Francis, J.D. Corbin, J.A. Beavo, and K. Ferguson Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase Gene 216 1 1998 Aug 17 139 147 (Pubitemid 28389111)
43. Y. Matsumoto, S. Unoki, H. Aonuma, and M. Mizunami Critical role of nitric oxide-cGMP cascade in the formation of cAMP-dependent long-term memory Learn. Mem. 13 1 2006 Jan-Feb 35 44 (Pubitemid 43200817)
44. C.R. Maxwell, S.J. Kanes, T. Abel, and S.J. Siegel Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications Neuroscience 129 1 2004 101 107 (Pubitemid 39360946)
45. F.S. Menniti, T.A. Chappie, J.M. Humphrey, and C.J. Schmidt Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia Curr. Opin. Investig. Drugs 8 1 2007 Jan 54 59 (Pubitemid 46438266)
46. F. Murad, C.K. Mittal, W.P. Arnold, S. Katsuki, and H. Kimura Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin Adv. Cyclic Nucleotide Res. 9 1978 145 158
47. J.J. Nelson Relieving select symptoms of the elderly Geriatrics 30 3 1975 133 139 142
48. E.J. Nestler, and S.E. Hyman Animal models of neuropsychiatric disorders Nat. Neurosci. 13 10 2010 Oct 1161 1169
49. C. Ng, M.I. Noblejas, J.S. Rodefer, C. Smith, and A. Poremba Double dissociation of attentional resources: prefrontal versus cingulate cortices J. Neurosci. 27 45 2007 12123 12131 (Pubitemid 350085468)
50. A. Nishi, M. Kuroiwa, D.B. Miller, J.P. O'Callaghan, H.S. Bateup, T. Shuto, N. Sotogaku, T. Fukuda, N. Heintz, P. Greengard, and G.L. Snyder Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum J. Neurosci. 28 42 2008 Oct 15 10460 10471
51. J.W. Olney, J.W. Newcomer, and N.B. Farber NMDA receptor hypofunction model of schizophrenia J. Psychiatr. Res. 33 6 1999 Nov-Dec 523 533
52. A.M. Owen, A.C. Roberts, C.E. Polkey, B.J. Sahakian, and T.W. Robbins Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man Neuropsychologia 29 10 1991 993 1006
53. C.S. Patil, V.P. Singh, and S.K. Kulkarni Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats Pharmacol. Rep. 58 3 2006 May-Jun 373 380 (Pubitemid 44111072)
54. B.P. Ramos, S.G. Birnbaum, I. Lindenmayer, S.S. Newton, R.S. Duman, and A.F. Arnsten Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline Neuron 40 4 2003 835 845 (Pubitemid 37431042)
55. B.P. Ramos, D. Stark, L. Verduzco, C.H. van Dyck, and A.F. Arnsten Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals Learn. Mem. 13 6 2006 Nov-Dec 770 776 (Pubitemid 44871678)
56. C.T. Randt, M.E. Judge, K.A. Bonnet, and D. Quartermain Brain cyclic AMP and memory in mice Pharmacol. Biochem. Behav. 17 4 1982 Oct 677 680 (Pubitemid 13208422)
57. O.A. Reneerkens, K. Rutten, H.W. Steinbusch, A. Blokland, and J. Prickaerts Selective phosphodiesterase inhibitors: a promising target for cognition enhancement Psychopharmacology (Berl.) 202 1-3 2009 Jan 419 443
58. E. Reyes-Irisarri, M. Markerink-Van Ittersum, G. Mengod, and J. de Vente Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains Eur. J. Neurosci. 25 11 2007 Jun 3332 3338 (Pubitemid 46872773)
59. T.W. Robbins, M. James, A.M. Owen, B.J. Sahakian, A.D. Lawrence, L. McInnes, and P.M. Rabbitt A study of performance on tests from the CANTAB battery sensitive to frontal lobe dysfunction in a large sample of normal volunteers: implications for theories of executive functioning and cognitive aging. Cambridge Neuropsychological Test Automated Battery J. Int. Neuropsychol. Soc. 4 1998 474 490 (Pubitemid 28461619)
60. J.S. Rodefer, and T.N. Nguyen Naltrexone reverses age-induced cognitive deficits in rats Neurobiol. Aging 29 2008 309 313
61. J.S. Rodefer, E.R. Murphy, and M.G. Baxter PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats Eur. J. Neurosci. 21 4 2005 1070 1076 (Pubitemid 40461058)
62. J.S. Rodefer, T.N. Nguyen, J.J. Karlsson, and J. Arnt Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics Neuropsychopharmacology 33 11 2008 Oct 2657 2666
63. G.M. Rose, A. Hopper, M. De Vivo, and A. Tehim Phosphodiesterase inhibitors for cognitive enhancement Curr. Pharm. Des. 11 26 2005 3329 3334 (Pubitemid 41300762)
64. K. Rutten, J.D. Vente, A. Sik, M.M. Ittersum, J. Prickaerts, and A. Blokland The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices Behav. Brain Res. 164 1 2005 Oct 14 11 16 (Pubitemid 41253727)
65. K. Rutten, J. Prickaerts, M. Hendrix, F.J. van der Staay, A. Sik, and A. Blokland Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors Eur. J. Pharmacol. 558 1-3 2007 Mar 8 107 112 (Pubitemid 46328881)
66. K. Rutten, C. Lieben, L. Smits, and A. Blokland The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat Psychopharmacology (Berl.) 192 2007 275 282 (Pubitemid 46669202)
67. K. Rutten, J.L. Basile, J. Prickaerts, A. Blokland, and J.A. Vivian Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques Psychopharmacology (Berl.) 196 2008 643 648
68. K. Rutten, J. Prickaerts, G. Schaenzle, H. Rosenbrock, and A. Blokland Sub-chronic rolipram treatment leads to a persistent improvement in long-term object memory in rats Neurobiol. Learn. Mem. 90 2008 569 575
69. K. Rutten, E.L. Van Donkelaar, L. Ferrington, A. Blokland, E. Bollen, H.W. Steinbusch, P.A. Kelly, and J.H. Prickaerts Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats Neuropsychopharmacology 24 2009 1914 1925
70. F. Sams-Dodd Effects of continuous d-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats Neuropsychopharmacology 19 1 1998 Jul 18 25 (Pubitemid 28255210)
71. C.J. Schmidt, D.S. Chapin, J. Cianfrogna, M.L. Corman, M. Hajos, J.F. Harms, W.E. Hoffman, L.A. Lebel, S.A. McCarthy, F.R. Nelson, C. Proulx-LaFrance, M.J. Majchrzak, A.D. Ramirez, K. Schmidt, P.A. Seymour, J.A. Siuciak, F.D. Tingley 3rd, R.D. Williams, P.R. Verhoest, and F.S. Menniti Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia J. Pharmacol. Exp. Ther. 325 2 2008 May 681 690 (Pubitemid 351574819)
72. D. Schultheiss, S.V. Müller, W. Nager, C.G. Stief, N. Schlote, U. Jonas, C. Asvestis, S. Johannes, and T.F. Münte Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials World J. Urol. 19 1 2001 Feb 46 50 (Pubitemid 33777032)
73. T.F. Seeger, B. Bartlett, T.M. Coskran, J.S. Culp, L.C. James, and D.L. Krull Immunohistochemical localization of PDE10A in the rat brain Brain Res. 985 2 2003 113 126 (Pubitemid 37088176)
74. R. Sircar Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-d-aspartate receptor upregulation Int. J. Dev. Neurosci. 21 3 2003 May 159 167 (Pubitemid 36444541)
75. J.A. Siuciak, D.S. Chapin, J.F. Harms, L.A. Lebel, S.A. McCarthy, and L. Chambers Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis Neuropharmacology 51 2 2006 386 396 (Pubitemid 44061894)
76. J.A. Siuciak, S.A. McCarthy, D.S. Chapin, R.A. Fujiwara, L.C. James, R.D. Williams, J.L. Stock, J.D. McNeish, C.A. Strick, F.S. Menniti, and C.J. Schmidt Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function Neuropharmacology 51 2 2006 374 385 (Pubitemid 44061880)
77. J.A. Siuciak, S.A. McCarthy, D.S. Chapin, A.N. Martin, J.F. Harms, and C.J. Schmidt Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background Neuropharmacology 54 2008 417 427
78. W.L. Smith, M.J. Philippus, and J.B. Lowrey A comparison of psychological and psychophysical test patterns before and after receiving papaverine HCL Curr. Ther. Res. Clin. Exp. 10 9 1968 428 431
79. W.S. Smith, C.F. Dowd, S.C. Johnston, N.U. Ko, S.J. DeArmond, and W.P. Dillon Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage Stroke 35 11 2004 2518 2522 (Pubitemid 39458410)
80. S.H. Soderling, and J.A. Beavo Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions Curr. Opin. Cell Biol. 12 2 2000 174 179 (Pubitemid 30142563)
81. F.H. Stern Management of chronic brain syndrome secondary to cerebral arteriosclerosis, with special reference to papaverine hydrochloride J. Am. Geriatr. Soc. 18 6 1970 507 512
82. A. Storch, S. Ott, Y.I. Hwang, R. Ortmann, A. Hein, and S. Frenzel Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter Biochem. Pharmacol. 63 5 2002 909 920 (Pubitemid 34243004)
83. G.W.C. Tam, L.N. van de Lagemaat, R. Redo, K.E. Strathdee, M.D.R. Croning, M.P. Mallory, W.J. Muir, B.S. Pickard, I.J. Deary, D.H.R. Blackwood, N.P. Carter, and S.G.N. Grant Confirmed rare copy number variants implicate novel genes in schizophrenia Boichem Soc. Trans. 38 part 2 2010 445 451
84. F.H. Treitz, K. Heyder, and I. Daum Differential course of executive control changes during normal aging Neuropsychol. Dev. Cogn. B. Aging Neuropsychol. Cogn. 14 4 2007 370 393 (Pubitemid 47027108)
85. S.M. Turgeon, E.A. Auerbach, and M.A. Heller The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm Pharmacol. Biochem. Behav. 60 2 1998 Jun 553 558 (Pubitemid 28282698)
86. W.C. van Staveren, H.W. Steinbusch, M. Markerink-van Ittersum, S. Behrends, and J. de Vente Species differences in the localization of cGMP-producing and NO-responsive elements in the mouse and rat hippocampus using cGMP immunocytochemistry Eur. J. Neurosci. 19 8 2004 Apr 2155 2168 (Pubitemid 38582204)
87. O.V. Vitolo, A. Sant'Angelo, V. Costanzo, F. Battaglia, O. Arancio, and M. Shelanski Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling Proc. Natl. Acad. Sci. U S A 99 20 2002 13217 13221
88. T.L. Wallace, P.M. Callahan, A. Tehim, D. Bertrand, G. Tombaugh, S. Wang, W. Xie, W.B. Rowe, V. Ong, E. Graham, A.V. Terry, J.S. Rodefer, B. Herbert, M. Murray, R. Porter, L. Santarelli, and D.A. Lowe RG3487, a novel nicotinic alpha7 receptor partial agonist, improves cognition and sensorimotor gating in rodents J. Pharmacol. Exp. Ther. 336 1 2011 Jan 242 253
89. J.L. Weeks, R. Zoraghi, A. Beasley, K.R. Sekhar, S.H. Francis, and J.D. Corbin High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients Int. J. Impot Res. 17 1 2005 Jan-Feb 5 9 (Pubitemid 40299987)
90. J.L. Weeks, M.A. Blount, A. Beasley, R. Zoraghi, M.K. Thomas, K.R. Sekhar, J.D. Corbin, and S.H. Francis Radiolabeled ligand binding to the catalytic or allosteric sites of PDE5 and PDE11 Methods Mol. Biol. 307 2005 239 262
91. J.A. Yesavage, J.R. Tinklenberg, L.E. Hollister, and P.A. Berger Vasodilators in senile dementias: a review of the literature Arch. Gen. Psychiatry 36 2 1979 220 223 (Pubitemid 9098808)
92. H.T. Zhang, and J.M. O'Donnell Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats Psychopharmacology (Berl.) 150 3 2000 Jun 311 316 (Pubitemid 30447851)
93. H.T. Zhang, A.M. Crissman, N.R. Dorairaj, L.J. Chandler, and J.M. O'Donnell Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism Neuropsychopharmacology 23 2 2000 Aug 198 204 (Pubitemid 30406904)
94. H.T. Zhang, Y. Zhao, Y. Huang, N.R. Dorairaj, L.J. Chandler, and J.M. ODonnell Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus Neuropsychopharmacology 29 2004 1432 1439 (Pubitemid 38982235)
95. H.T. Zhang, Y. Huang, K. Mishler, S.C. Roerig, and J.M. O'Donnell Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats Psychopharmacology (Berl.) 182 1 2005 Oct 104 115 (Pubitemid 41400867)
96. H.T. Zhang Phosphodiesterase targets for cognitive dysfunction and schizophrenia-a New York Academy of Sciences Meeting IDrugs 13 3 2010 Mar 166 168
97. M. Zhuo, Y. Hu, C. Schultz, E.R. Kandel, and R.D. Hawkins Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation Nature 368 6472 1994 Apr 14 635 639 (Pubitemid 24153387)